#PressRelease

In #Redefine1 RCT of 3417 ppl w overweight/obesity & one/more comorbidities
🔺#cagrisema 2.4/2.4 mg sc/wk -> more wt loss than #cagrilintide 2.4mg or #semaglutide 2.4mg or placebo at 68 wks even though lower % reached target dose than w each component
https://www.novonordisk.com/news-and-media/ne…